Rare pituitary tumor treated with medicine during pregnancy
Original title: Thyroid-stimulating hormone-secreting pituitary neuroendocrine tumor (TSH-PitNet) diagnosed during pregnancy and treated with a somatostatin analog.
How far along is this research?
- Lab cells
- Animals
- Review
- Tested in people
This was tested in people. That is the most reliable kind of research we share.
This is a report about one patient, not a study that tested the drug in a group of people.
The short version
A woman had a rare pituitary tumor while pregnant, and she and her baby did well.
What was studied. This is a report about one patient. She was a woman in her mid-20s, pregnant with her first baby. Doctors used blood tests and an MRI scan to find the cause of her symptoms.
What they found. At 12 weeks of pregnancy, her blood test showed a high thyroid hormone level. The MRI showed a tumor in her pituitary gland. She got a shot of a drug called lanreotide once a month, starting at 18 weeks. At 40 weeks she had an emergency cesarean birth, and her baby was healthy. Doctors removed the tumor three months after the birth.
What this means, and what it doesn't
What it could mean: For this kind of rare tumor, doctors may be able to use medicine during pregnancy. Surgery can sometimes wait until after the baby is born. Close checkups are part of that plan.
What it doesn't mean: This is one person's story, not a trial. It does not prove the drug is safe or helpful for other people. One good result cannot tell us what happens in most cases. This is not a cure, and it is not a plan that fits every patient. Your own care may look different. Talk with your own doctor.
Source: PubMed, September 1, 2026 · Read the original
This plain-language summary was written by AI and published automatically after passing our automatic safety checks. How we write.